Speakers

James Miskin

 • Oxford BioMedica (UK) Ltd

Dr Miskin joined Oxford Biomedica in 2000. He has more than 17 years experience in the GxP environment. In his current role, he has overall responsibility for Oxford Biomedica’s Quality systems, analytical testing, lentiviral based bioprocessing development and client programmes. He is also a named inventor on several patents in the field. He holds a Bachelor of Science degree and a PhD in Molecular Biology from the University of Leeds and subsequently conducted post-doctoral research at The Pirbright Institute for a number of years. He is an active member of the UK BioIndustry Association Manufacturing Advisory Committee and is the Advanced Therapies work stream lead for The Medicines Manufacturing Industry Partnership (MMIP).

Also Speaking

Kim Raineri

Chief Manufacturing and Technology Officer • AVROBIO

Louis Walcer

Director, The Kevin M. McGovern Family Center for Venture Development in the Life Sciences • Cornell University

Michael Leek

Executive Chairman • TC BioPharm
Michael has 30 years’ experience in regenerative medicine, during which he progressed 10 different cell-based products from the laboratory into clinic. As co-founder, he was jointly responsible for moving Intercytex from a pre-clinical research company, to an AIM-listed biotech with several cell therapy products in the clinic. He has extensive GMP manufacture expertise which includes management of several FDA/EMEA/MHRA licensed GMP facilities. Additionally, Michael has clinical, regulatory and logistic expertise and he has directly raised over $60m in equity and grant funding. In 2017, Michael received the ‘Scottish Life-Sciences Entrepreneurial Business Leadership’ award for 2016-2017. Michael is also a Fellow of the Royal Society of Medicine and Honorary Lecturer at the University of Aberdeen, School of Medical Sciences.

Event Info

Image

Fun Run